A detailed history of Geode Capital Management, LLC transactions in Procaps Group, S.A. stock. As of the latest transaction made, Geode Capital Management, LLC holds 28,938 shares of PROC stock, worth $16,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,938
Previous 28,938 -0.0%
Holding current value
$16,494
Previous $72,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$2.78 - $4.7 $9,874 - $16,694
3,552 Added 13.99%
28,938 $83,000
Q4 2023

Feb 13, 2024

BUY
$2.18 - $4.14 $9,075 - $17,234
4,163 Added 19.62%
25,386 $103,000
Q1 2023

May 15, 2023

BUY
$3.68 - $5.27 $9,428 - $13,501
2,562 Added 13.73%
21,223 $95,000
Q1 2022

May 13, 2022

BUY
$7.97 - $9.85 $60,906 - $75,273
7,642 Added 69.35%
18,661 $158,000
Q4 2021

Feb 11, 2022

BUY
$8.85 - $10.42 $97,518 - $114,817
11,019 New
11,019 $107,000

Others Institutions Holding PROC

About Procaps Group, S.A.


  • Ticker PROC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 112,824,000
  • Market Cap $64.3M
  • Description
  • Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...
More about PROC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.